Changes in the illness perceptions of patients with rheumatoid arthritis over the first year of methotrexate therapy
Authors:
- James M GwinnuttJGJames M Gwinnutt
- Sam NortonSNSam Norton
- Kimme L HyrichKHKimme L Hyrich
- Mark LuntMLMark Lunt
- Anne BartonABAnne Barton
- Lis CordingleyLCLis Cordingley
- Suzanne M M VerstappenSVSuzanne M M Verstappen
- for the RAMS co-investigatorsFCfor the RAMS co-investigators
Open Access
- 14 November 2020
- journal article
- research article
- Published by Oxford University Press (OUP) in Rheumatology
- Vol. 60 (5) , 2355-2365
Abstract
To describe the illness perceptions of patients with RA over the first year of MTX treatment, and the association between illness perceptions and outcomes. Data came from the Rheumatoid Arthritis Medication Study (RAMS), a UK multicentre cohort study of RA patients starting MTX for the first time. Patients were assessed at baseline, and at 6 and 12 months. Patients completed the Brief Illness Perception Questionnaire (B-IPQ) at each assessment, as well as other patient-reported outcomes (PROs). The inflammation score (2-component DAS28) was calculated. Subgroups of patients with similar trajectories across the eight (B-IPQ) items were identified using a latent class growth model. Predictors of group membership were identified using multinomial logistic regression. Associations between subgroups and PROs over follow-up were assessed using linear mixed models. Three subgroups were identified in the analysis population (N = 1087): Positive illness perceptions (N = 322), Negative illness perceptions (N = 534) and Improvers (N = 231) who switched from negative to positive illness perceptions over follow-up. Baseline disability was associated with group membership [Positive vs Negative: relative risk ratio (RRR) 0.37, 95% CI: 0.25, 0.54; Improvers vs Negative: RRR 0.60, 95% CI: 0.43, 0.83], as were other PROs (pain, fatigue, anxiety, depression). The Negative group had worse disability, pain and fatigue over follow-up compared with the other groups, controlling for inflammation. Negative illness perceptions are associated with poor PROs over time. The Improvers subgroup illustrated that illness perceptions can change in RA. Illness perceptions represent a potential therapeutic target that should be assessed using randomized trials.Keywords
Funding Information
- Versus Arthritis (20385, 20380)
- NIHR Manchester Biomedical Research Centre
This publication has 39 references indexed in Scilit:
- Negative and positive illness representations of rheumatoid arthritis: a latent profile analysisJournal of Behavioral Medicine, 2013
- Illness perceptions in patients receiving rheumatology rehabilitation: association with health and outcomes at 12 monthsBMC Musculoskeletal Disorders, 2013
- Illness perceptions account for variation in positive outlook as well as psychological distress in Rheumatoid ArthritisPsychology, Health & Medicine, 2012
- Association between socioeconomic status, learned helplessness, and disease outcome in patients with inflammatory polyarthritisArthritis Care & Research, 2012
- An evaluation of a biopsychosocial framework for health-related quality of life and disability in rheumatoid arthritisJournal of Psychosomatic Research, 2011
- Predictors of Clinical Response and Radiographic Progression in Patients with Rheumatoid Arthritis Treated with Methotrexate MonotherapyThe Journal of Rheumatology, 2010
- Illness perceptions in patients with osteoarthritis: Change over time and association with disabilityArthritis Care & Research, 2009
- Prognostic factors of 10-year radiographic outcome in early rheumatoid arthritis: a prospective studyArthritis Research & Therapy, 2008
- Modified disease activity scores that include twenty-eight-joint counts development and validation in a prospective longitudinal study of patients with rheumatoid arthritisArthritis & Rheumatism, 1995
- The Hospital Anxiety and Depression ScaleActa Psychiatrica Scandinavica, 1983